Werner v. American-Edwards Laboratories, Inc.

745 P.2d 1055, 113 Idaho 434, 1987 Ida. LEXIS 352
CourtIdaho Supreme Court
DecidedOctober 29, 1987
Docket16518
StatusPublished
Cited by6 cases

This text of 745 P.2d 1055 (Werner v. American-Edwards Laboratories, Inc.) is published on Counsel Stack Legal Research, covering Idaho Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Werner v. American-Edwards Laboratories, Inc., 745 P.2d 1055, 113 Idaho 434, 1987 Ida. LEXIS 352 (Idaho 1987).

Opinions

HUNTLEY, Justice.

Plaintiff Rose M. Werner, individually and as guardian ad litem for Arthur Werner, appeals the trial court’s grant of summary judgment to defendants Duane A. Daugharty, M.D. and Eugene M. Trout, M.D., on grounds that Werner’s claims for professional malpractice were barred by the statute of limitations. To explain the complex and uncertain factual setting, a protracted statement of the facts is necessary.

In 1964, Arthur Werner, then forty-six years old, had his diseased aortic valve replaced with a Starr-Edwards aortic heart valve. At the time, Werner was under the care of Dr. Daugharty, a specialist in internal medicine. In April, 1965, Werner suffered a minor stroke caused by embolization from the prosthetic heart valve. Thereafter, Dr. Daugharty prescribed Coumadin, an anticoagulant, for Werner. Dr. Daugharty further suggested that Werner have the heart valve replaced with an aortic homograft, but Arthur Werner declined further surgery.

Arthur Werner continued to take Coumadin as an anticoagulant until November 1978. At that time, Dr. Daugharty discontinued the prescription of Coumadin because Werner had a high prothrombin time (since Werner occasionally failed to take the medication prescribed) and had a history of repeated trauma and injury. Dr. Daugharty placed Werner on a prescription of aspirin and Persantine, the combination of which served as an anticoagulant. Arthur Werner last saw Dr. Daugharty on August 8, 1981.

Later that month, Arthur Werner began seeing Dr. Trout as his primary physician. The medical records show the notation “d/c Persantine.” In medical parlance, “d/c” generally is shorthand for the word “discontinue.” In his deposition, Dr. Trout acknowledged the existence of the notation and that the notation “looks like a recommendation,” but testified that he could not remember ordering the discontinuation of Persantine. (The record is unclear as to when the “d/e Persantine” notation, if valid, was made). On December 1, 1981, Arthur Werner came to Dr. Trout complaining of chest pains. Suspecting heart problems of some sort, Dr. Trout ordered chest x-rays which were generally inconclusive. According to the medical records, Dr. Trout wrote his diagnosis as being hypertension, but also testified that he thought the incident might be due to heart problems. The following excerpt from Dr. Trout’s deposition indicates the inconclusive state of facts surrounding the December 1,1981 visit and the amount and kind of medication Werner was then receiving.

Q. Okay, so 12-01-81, he comes back in. And apparently, at that point, you made the reference there, “Persantine didn’t help.”
A. Yes.
Q. What was that referring to?
A. Well, he was still on the Persantine. That’s why I — the only thing I can gather from this — that I didn’t — if I did recommend to discontinue it, he probably didn’t. What also might have happened is that he did discontinue it. But when he had these symptoms, he decided, oops. Persantine’s for my heart. I’d better take some. So he took some, and it didn’t help. That’s probably what happened.
Q. And so at that point, you prescribed 25 milligrams?
A. Yes. I — at that point, if — my memory being what it is — I probably told him to start taking it again.

There were also notations on the medical records where Dr. Trout recommended doubling Werner’s Persantine prescription to 50 milligrams per day, and some mention that the prescribed dosage may, at some time, have been as high as 200 milligrams per day.

As is apparent, the deposition testimony of Dr. Trout provides a confusing explanation concerning Werner’s treatment subsequent to August 1981. Indeed, Dr. Trout himself testified to being confused as to the facts.

[436]*436Q. So basically, we have then — apparently, was that an earlier recommendation or writing; and then subsequently, you changed that with the 50 milligrams?
MR. QUANE: I don’t think he said that.
THE WITNESS: Well, see at the top where it says Persantine, 25 milligrams?
Q. (By Mr. Owens) Yes.
A. That’s what he was taking when he came to me. And at the bottom is the advice to double it. This is where my confusion is.
Q. Uh-huh?
A. He was taking — he—when I said stop it, he may have stopped. He may have started it again. I don’t know.
Q. Okay. Or you may just have been referring to the fact that that was your understanding of what he had been taking, prior to the time you told him to discontinue it — the 25 milligrams?
A. Yes.

Lending further confusion to the record, contrary to Dr. Trout’s written record that he diagnosed hypertension as a cause of the chest pains on December 1, 1981, he later stated in his deposition that he did not reach any diagnosis, but had “questions in my mind — did he have some heart failure?”. Subsequent medical records dated December 10, 1981, indicate that Werner had not experienced chest pains “since stopping Persantine.”

The record as a whole, despite detailing numerous conflicting courses of treatment arising out of the December 1, 1981, incident, does not explain the cause of that incident. The record alludes only to either hypertension or heart failure and at no place suggests the symptoms of that date were related to embolism originating from the situs of the heart valve. Neither does the record relate the symptomology on December 1st, 1981 to the prescription or nonprescription of drugs.

Shortly after the December visits with Dr. Trout, Werner suffered a massive stroke on March 31, 1982. The Werners filed claim on March 28, 1984, with Rose Werner appointed as guardian ad litem for Arthur Werner, November 10, 1985. On November 29, 1985, Arthur Werner died.

The trial court granted summary judgment on grounds that plaintiff had failed to file the cause of action within the applicable statute of limitations, I.C. § 5-219(4), which provides that actions for personal injury and professional malpractice must be filed within two years of the accrual of a cause of action. I.C. § 5-219(4) provides in pertinent part: “The cause of action shall be deemed to have accrued as of the time of the occurrence, act or omission complained of____”

Construing the above language, the trial court held that Werners’ cause of action accrued when some damage occurred — in this case, when a “process of continued embolization” began to occur once Werner was removed from Coumadin in 1978, or, the date of Werner’s last visit to either Dr. Daugharty or Dr. Trout, ruling that, in either event, the cause of action was not timely. The trial court noted that plaintiffs, by their own allegations in their second amended complaint stated that any damage occurred due to an alleged failure to provide proper treatment. Any such inadequate treatment, or failure to provide treatment, the trial court ruled, had “occurred” by the time of Werner’s last visit to the doctors. We are called upon to decide whether the trial court appropriately granted summary judgment.

We note at the outset that, on review, this Court must view the facts in a light most favorable to the nonmoving party when reviewing the grant of summary judgment. Jones v. City of St.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Weiss v. Rojanasathit
975 S.W.2d 113 (Supreme Court of Missouri, 1998)
Brower v. EI DuPont De Nemours and Co.
792 P.2d 345 (Idaho Supreme Court, 1990)
Hawley v. Green
788 P.2d 1321 (Idaho Supreme Court, 1990)
Adams v. Armstrong World Industries, Inc.
847 F.2d 589 (Ninth Circuit, 1988)
Adams v. Armstrong World Industries
847 F.2d 589 (Ninth Circuit, 1988)
Werner v. American-Edwards Laboratories, Inc.
745 P.2d 1055 (Idaho Supreme Court, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
745 P.2d 1055, 113 Idaho 434, 1987 Ida. LEXIS 352, Counsel Stack Legal Research, https://law.counselstack.com/opinion/werner-v-american-edwards-laboratories-inc-idaho-1987.